RxDoctor Payments Data
★ My doctorsLook up a doctor →

Christopher Bondoc

Neurology · Commack, NYNPI 1528555117

Payments from drug & device makers

$7,132in general payments, 2019–2025

Across 319 payments — averaging $22.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lundbeck LLC$459
  • Merz Pharmaceuticals, LLC$414
  • Takeda Pharmaceuticals U.S.A., Inc.$409
  • Neurocrine Biosciences, Inc.$400
  • Axsome Therapeutics, Inc.$379
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$7,132100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie107$1,736
Lundbeck LLC23$459
Merz Pharmaceuticals, LLC15$414
Takeda Pharmaceuticals U.S.A., Inc.13$409
Neurocrine Biosciences, Inc.14$400
Axsome Therapeutics, Inc.15$379
Harmony Biosciences LLC14$317
Pfizer14$293
Amneal Pharmaceuticals LLC14$290
Medtronic2$247
Grifols USA, LLC8$208
Argenx US, Inc.7$203
UCB, Inc.6$153
Jazz Pharmaceuticals Inc.5$131
SK Life Science, Inc.4$120
Ipsen Biopharmaceuticals, Inc4$107
AstraZeneca(2 entities)5$105
Kyowa Kirin, Inc.4$103
Inspire Medical Systems, Inc.3$86
Octapharma USA, Inc.4$86
ZOLL Respicardia, Inc.1$70
Catalyst Pharmaceuticals, Inc.3$64
Genentech USA, Inc.2$63
Eisai Inc.3$63
Tanabe Pharma America, Inc.3$57
Protega Pharmaceutials Inc3$52
Alnylam Pharmaceuticals Inc.2$51
Lilly USA, LLC1$50
Scilex Pharmaceuticals Inc.2$48
Tonix Medicines, Inc.2$36
Otsuka America Pharmaceutical, Inc.2$35
Sanofi1$32
Acadia Pharmaceuticals Inc2$30
GE HealthCare1$29
Biogen1$28
Abbott1$25
Impel Pharmaceuticals LLC1$20
Amgen1$20
Vanda Pharmaceuticals Inc.1$20
Vertex1$20
Amylyx Pharmaceuticals, Inc.1$20
Microtransponder, Inc.1$19
EMD Serono, Inc.1$17
Acorda Therapeutics, Inc1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,132 in reported general payments places this provider in the 65th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate16$25,313
UbrelvyUbrogepant16$19,348
Pregabalin19$1,445
Amitriptyline Hcl66$405
Carbamazepine ErCarbamazepine11$388
Gabapentin35$328
Topiramate23$282
Donepezil Hcl37$238
Sumatriptan Succinate35$208
Memantine Hcl13$172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$293$25,31316 claims
AbbVieUbrelvy$1,736$19,34816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,623 neurology providers in New York.

Other neurology in Commack

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →